Clinical Trials Sponsored by Millennium: The Takeda Oncology Company
Total 20 results
-
Centre Antoine LacassagneMillennium: The Takeda Oncology CompanyCompletedSafety | Clinical EfficacyFrance
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyCompleted
-
M.D. Anderson Cancer CenterMillennium: The Takeda Oncology CompanyTerminated
-
Oregon Health and Science UniversityMillennium: The Takeda Oncology CompanyCompletedMultiple Myeloma | Heart Failure, Systolic | Cardiotoxins
-
Memorial Sloan Kettering Cancer CenterMillennium: The Takeda Oncology CompanyCompletedMyeloid Hematologic Malignancy | Lymphoid Hematologic MalignancyUnited States
-
Marjolein SpieringMillennium: The Takeda Oncology CompanyUnknownHodgkin Lymphoma | Relapse | RefractoryNetherlands, France, Denmark, United Kingdom
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of OxfordNational Institute for Health Research, United Kingdom; European Commission; Oxford... and other collaboratorsTerminatedOsteosarcomaUnited Kingdom, Germany, Italy, Netherlands, Norway
-
Federation of Italian Cooperative Oncology GroupsBristol-Myers Squibb; Eli Lilly and Company; Bayer; Novartis; Roche Pharma AG; Takeda; AstraZene... and other collaboratorsRecruiting
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsUnknown
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
Foundation for the National Institutes of HealthEli Lilly and Company; National Institute of Diabetes and Digestive and Kidney... and other collaboratorsCompleted
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsUnknown
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsWithdrawnGalunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Colorectal Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsUnknownColorectal Cancer Metastatic
-
Pulnovo Medical (Wuxi) Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsRecruitingCardiovascular Diseases | Vascular Diseases | Heart Failure | Hypertension | Pulmonary Hypertension | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection FractionChina